HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara De Martin Selected Research

glycinexylidide

12/2006Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
1/2003Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara De Martin Research Topics

Disease

13Liver Diseases (Liver Disease)
05/2022 - 06/2002
8Fibrosis (Cirrhosis)
12/2021 - 01/2003
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2002
4Non-alcoholic Fatty Liver Disease
04/2022 - 07/2019
4Neoplasms (Cancer)
12/2021 - 10/2019
4Inflammation (Inflammations)
06/2021 - 01/2018
2Autoimmune Hepatitis
05/2022 - 12/2018
2Obesity
11/2020 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
09/2020 - 10/2019
2Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 03/2020
1COVID-19
05/2022
1Fatty Liver
04/2022
1Vascular Calcification
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
01/2022
1Medulloblastoma
01/2021
1Weight Loss (Weight Reduction)
11/2020
1Infections
09/2020
1Leukemia
10/2019
1Mental Disorders (Mental Disorder)
10/2019
1Bipolar Disorder (Manic Depressive Psychosis)
10/2019
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2019
1Schizophrenia (Dementia Praecox)
10/2019
1Hepatitis
12/2018
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
12/2018
1Immune System Diseases (Immune Disorders)
01/2018
1Cholestasis
01/2018
1Dysbiosis
10/2017
1Type 2 Diabetes Mellitus (MODY)
02/2017
1Alcoholic Fatty Liver
02/2017
1Autoimmune Diseases (Autoimmune Disease)
12/2016
1Ischemia
07/2015
1Hepatic Insufficiency
10/2014
1Heart Failure
03/2010
1Renal Insufficiency (Renal Failure)
12/2006
1Chronic Kidney Failure (Chronic Renal Failure)
12/2006

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
04/2022 - 01/2004
7EnzymesIBA
12/2021 - 01/2008
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
10/2014 - 01/2003
4Lidocaine (Xylocaine)FDA LinkGeneric
12/2006 - 01/2003
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2021 - 10/2014
3nemorosoneIBA
07/2020 - 10/2019
3Propolis (Bee Bread)IBA
07/2020 - 10/2019
3Protein Isoforms (Isoforms)IBA
01/2016 - 01/2008
3Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2013 - 05/2006
3monoethylglycinexylidide (L 86)IBA
12/2006 - 01/2003
2Cytochrome P-450 CYP3AIBA
12/2021 - 10/2014
2Pregnane X ReceptorIBA
12/2021 - 10/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 10/2014
2Messenger RNA (mRNA)IBA
01/2018 - 10/2014
2Fluvoxamine (Luvox)FDA LinkGeneric
03/2010 - 05/2006
2glycinexylidideIBA
12/2006 - 01/2003
2CreatinineIBA
12/2006 - 06/2002
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2022
1SteroidsIBA
05/2022
1VaccinesIBA
05/2022
1SofosbuvirIBA
04/2022
1Uridine Monophosphate (UMP)IBA
04/2022
1Indicators and Reagents (Reagents)IBA
04/2022
1Phosphates (Orthophosphate)IBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2021
1Tyrosine Kinase InhibitorsIBA
12/2021
1Liposomes (Liposome)IBA
12/2021
1ProdrugsIBA
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
06/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1MicellesIBA
01/2021
1glabrescione BIBA
01/2021
1SubtilisinIBA
11/2020
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
11/2020
1Proprotein Convertase 9IBA
09/2020
1SugarsIBA
01/2020
1Dopamine (Intropin)FDA LinkGeneric
10/2019
1Amphetamine (Amfetamine)FDA LinkGeneric
10/2019
1Bile Acids and Salts (Bile Acids)IBA
07/2019
1AutoantibodiesIBA
12/2018
1Cholinergic Agents (Cholinergics)IBA
10/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2017
1Anti-Bacterial Agents (Antibiotics)IBA
10/2017
1AmylasesFDA Link
02/2017
1Glucose (Dextrose)FDA LinkGeneric
02/2017
1GlucosidasesIBA
02/2017
1Immunomodulating AgentsIBA
12/2016
1NAD (NADH)IBA
07/2015
1Sirtuin 1IBA
07/2015
1Carbon Tetrachloride (Tetrachloromethane)IBA
10/2014
1Proteins (Proteins, Gene)FDA Link
10/2014
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2013
1Benzo(a)pyreneIBA
01/2013
1Blood Proteins (Serum Proteins)IBA
10/2010

Therapy/Procedure

3Therapeutics
12/2021 - 01/2018
2Immunomodulation
12/2021 - 10/2019
2Liver Transplantation
06/2021 - 12/2018
1Oral Administration
04/2022
1Bariatric Surgery
11/2020
1Glycemic Control
01/2020
1Ligation
01/2018
1Renal Dialysis (Hemodialysis)
12/2006